|
|
Article: For skin types IV-VI, Sculptra just as effective.(NEWS)
- Article from:
- Skin & Allergy News
- Article date:
- April 1, 2009
- Author:
CopyrightCOPYRIGHT 2009 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MAUI, HAWAII -- Injectable poly-L-lactic acid is at least as safe and effective in patients with darker skin as in those with Fitzpatrick skin types I-III, according to a multicenter postmarketing study.
The ongoing study also demonstrated that there were no sex differences in response to treatment. The study was mandated by the Food and Drug Administration as a condition of Sculptra's approval for correction of HIV-related facial lipoatrophy because the original clinical trials were heavily skewed toward white males, Dr. Douglas Mest explained at the annual Hawaii dermatology seminar sponsored by Skin Disease Education Foundation.
"What I found most ...